Company Monitoring Page for Incyte

latest headlines for company on cafepharma

Merck Accelerates Cancer-Immunotherapy Program With Three Collaborations
TheStreet.com
Wed, 02/5/14 - 08:42 am
Tags:
cancer immunotherapy, Merck, Amgen, Incyte, Pfizer, Bristol-Myers Squibb, MK-3475
Novartis Oncology chief Hoppenot leaps to the CEO job at partner Incyte
Fierce Pharma
Tue, 01/14/14 - 09:17 am
Tags:
Novartis, Incyte, pharmaceutical executives
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
Tags:
biotech, M&A, Alexion, Biomarin, Incyte, Medivation, Idenix, Insmed, InterMune, Puma Biotechnology, Vertex Pharmaceuticals
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
Tags:
JPMHC 2014, GSK, Intercept Pharma, Acorda Therapeutics, Cell Therapeutics, Novartis, Sanofi, Alnylam, Idenix, Alexion, Galena Biopharma, Incyte, Clovis Oncology, Dendreon, Merck, Arena Pharmaceuticals
What’s Next for Biotech?
Barron's
Fri, 01/10/14 - 06:47 pm
Tags:
Celgene, Alexion, Incyte, Biomarin
Why Did These 3 Biotechs Fail to Rally?
Motley Fool
Mon, 12/2/13 - 04:57 pm
Tags:
Incyte, Questcor Pharmaceuticals, Acthar, Techne
Multiple Reasons To Buy Incyte
Seeking Alpha
Sat, 11/9/13 - 12:42 pm
Tags:
Incyte
Geron's Promising News Poses No Threat To Incyte
Seeking Alpha
Fri, 11/8/13 - 11:59 am
Tags:
Geron, Incyte, stem cells, imetelstat
Incyte Earnings Show Product and Pipeline Progress
Motley Fool
Fri, 11/1/13 - 04:47 pm
Tags:
Incyte, earnings
Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tue, 10/29/13 - 09:42 am
Tags:
Clovis Oncology, Synta, Incyte, CO-1686, non-small cell lung cancer, ganetespib, INCB39110, rheumatoid arthritis
Incyte Has First-Mover Advantage
Motley Fool
Wed, 10/2/13 - 10:10 am
Tags:
Incyte, myelofibrosis, Jakafi, Novartis
Myelofibrosis Battle: Novartis Vs. Sanofi
Seeking Alpha
Tue, 09/10/13 - 04:25 pm
Tags:
Novartis, Sanofi, myelofibrosis, Jakafi, Incyte, SAR302503
This Biotech Has So Many Reasons to Be Liked
Motley Fool
Fri, 09/6/13 - 09:12 am
Tags:
Incyte, JAK inhibitors, Jakafi, myelofibrosis
Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
Tags:
biotech, M&A, ONYX Pharmaceuticals, Alexion, Biomarin, Incyte, Medivation, Pharmacyclics, Regeneron, Seattle Genetics
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 08/24/13 - 11:46 am
Tags:
Incyte, Novartis, Astex, Pacific Biosciences
Pop-Worthy Data, Incyte, but Let's See More
Motley Fool
Sat, 08/24/13 - 11:42 am
Tags:
Incyte, Jakafi, pancreatic cancer
Biotech Buyouts: Who's Next?
Motley Fool
Thu, 08/22/13 - 05:35 pm
Tags:
M&A, ONYX Pharmaceuticals, Amgen, Seattle Genetics, Medivation, Incyte
Does Incyte Deserve Its New Valuation?
Motley Fool
Thu, 08/22/13 - 09:14 am
Tags:
Incyte, JAK inhibitors, Jakafi, pancreatic cancer
Incyte pancreatic cancer drug improves survival in mid-stage trial
Reuters
Wed, 08/21/13 - 10:18 am
Tags:
Incyte, pancreatic cancer, Jakafi
Is This Myelofibrosis Drug a Blockbuster?
Motley Fool
Sat, 08/17/13 - 10:36 am
Tags:
myelofibrosis, Jakafi, Incyte

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.